Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Elimination of falsely reactive results in a commercially-available West Nile virus IgM capture enzyme-linked immunosorbent assay by heterophilic antibody blocking reagents.

Prince HE, Lapé-Nixon M, Givens TS, Bradshaw T, Nowicki MJ.

J Immunol Methods. 2017 May;444:24-28. doi: 10.1016/j.jim.2017.02.007. Epub 2017 Feb 16.

PMID:
28216236
2.

Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US.

Pawloski LC, Plikaytis BD, Martin MD, Martin SW, Prince HE, Lapé-Nixon M, Tondella ML.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e15-e21. doi: 10.1093/jpids/piw035.

PMID:
27451419
3.

Comparison of Enzyme Immunoassays for Detection of Antibodies to Hepatitis D Virus in Serum.

Chow SK, Atienza EE, Cook L, Prince H, Slev P, Lapé-Nixon M, Jerome KR.

Clin Vaccine Immunol. 2016 Aug 5;23(8):732-4. doi: 10.1128/CVI.00028-16. Print 2016 Aug.

4.

Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy.

Prince HE, Lapé-Nixon M.

Clin Vaccine Immunol. 2014 Oct;21(10):1377-84. doi: 10.1128/CVI.00487-14. Epub 2014 Aug 27. Review.

5.

Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.

Prince HE, Lapé-Nixon M, Brenner A, Pitstick N, Couturier MR.

Clin Vaccine Immunol. 2014 Jun;21(6):813-6. doi: 10.1128/CVI.00106-14. Epub 2014 Mar 26.

6.

Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity.

Prince HE, Lapé-Nixon M, Novak-Weekley SM.

Clin Vaccine Immunol. 2014 Jun;21(6):808-12. doi: 10.1128/CVI.00105-14. Epub 2014 Mar 26.

7.
8.

Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.

Prince HE, Yeh C, Lapé-Nixon M.

Clin Vaccine Immunol. 2011 Nov;18(11):1951-6. doi: 10.1128/CVI.05278-11. Epub 2011 Aug 31.

9.
10.

Evaluation of a multiplex bead-based screening assay for detection of binding antibodies to interferon-beta.

Lapé Nixon M, Matud J, Yeh C, Prince HE.

J Neuroimmunol. 2009 May 29;210(1-2):104-7. doi: 10.1016/j.jneuroim.2009.03.009. Epub 2009 Apr 3.

PMID:
19345423
11.

Development of a more efficient algorithm for identifying false-positive reactivity results in a dengue virus immunoglobulin M screening assay.

Prince HE, Yeh C, Lapé-Nixon M.

Clin Vaccine Immunol. 2008 Aug;15(8):1304-6. doi: 10.1128/CVI.00157-08. Epub 2008 Jun 18.

12.

Persistence of antibodies to West Nile virus nonstructural protein 5.

Prince HE, Lapé-Nixon M, Yeh C, Tobler LH, Busch MP.

J Clin Virol. 2008 Sep;43(1):102-6. doi: 10.1016/j.jcv.2008.03.025. Epub 2008 May 8.

PMID:
18467165
13.

Identification of interferon-beta antibodies in a reference laboratory setting: findings for 1144 consecutive sera.

Prince HE, Lapé-Nixon M, Audette C, Van Horn K.

J Neuroimmunol. 2007 Oct;190(1-2):165-9. Epub 2007 Sep 21.

PMID:
17889376
14.

Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.

Prince HE, Lapé-Nixon M, Matud J.

Clin Vaccine Immunol. 2006 Feb;13(2):266-70.

15.

Utilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infection.

Prince HE, Lapé-Nixon M, Busch MP, Tobler LH, Foster GA, Stramer SL.

Clin Diagn Lab Immunol. 2005 Sep;12(9):1123-6.

16.

Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.

Prince HE, Tobler LH, Lapé-Nixon M, Foster GA, Stramer SL, Busch MP.

J Clin Microbiol. 2005 Sep;43(9):4316-20.

17.

Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay.

Prince HE, Lapé-Nixon M.

Clin Diagn Lab Immunol. 2005 Jan;12(1):231-3.

20.

Supplemental Content

Loading ...
Support Center